Trial Profile
Effect of neoadjuvant trastuzumab administered concomitantly or sequentially in patients with HER2 positive invasive breast cancers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 May 2015
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 15 May 2015 New trial record